Compare FOXF & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOXF | DRTS |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | Israel |
| Employees | N/A | 121 |
| Industry | Motor Vehicles | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.0M | 641.6M |
| IPO Year | 2013 | N/A |
| Metric | FOXF | DRTS |
|---|---|---|
| Price | $18.01 | $8.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $30.25 | $8.67 |
| AVG Volume (30 Days) | 399.0K | ★ 421.8K |
| Earning Date | 05-07-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,467,321,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.90 | $699.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.27 | N/A |
| 52 Week Low | $13.08 | $2.81 |
| 52 Week High | $31.18 | $9.07 |
| Indicator | FOXF | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.64 | 59.76 |
| Support Level | $15.58 | $6.47 |
| Resistance Level | $18.21 | $8.60 |
| Average True Range (ATR) | 0.95 | 0.63 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 31.96 | 66.63 |
Fox Factory Holding Corp is a designer, manufacturer, and marketer of performance-defining products and systems used predominantly on bikes, Side-by-Sides, on-road vehicles with and without off-road capabilities, off-road vehicles and trucks, ATVs, snowmobiles, specialty vehicles and applications, motorcycles, and commercial trucks. Its business operates under the FOX, FOX RACING SHOX, and RACE FACE brands. Geographically, it derives a majority of revenue from North America and also has a presence in Asia, Europe, and the Rest of the World. The company operates in three segments: Powered Vehicles Group, Aftermarket Applications Group, and Specialty Sports Group, of which it derives maximum revenue from Specialty Sports Group segment.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.